✦ LIBER ✦

Design and Rationale for Randomized, Doubleblind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Patients With Diabetic Nephropathy (DN)

✍ Scribed by Sabounjian, LuAnn; Shipley, James; Braman, Virginia; Harnett, Mark; Wu, Lijun; Turnquist, David; Graham, Philip

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

929a A Phase 2, Randomized, Double-blind

✍ Lembo, Anthony; Camilleri, Michael; McCallum, Richard W.; Sastre, Ramon F.; Bret 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Novel design for a phase IIa placebo-con

✍ Joanna M Zakrzewska,Joanne Palmer,Dominik A Ettlin,Mark Obermann… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 456 KB

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONT

✍ Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A phase 2, double-blind, randomized, pla

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB

A randomized, double-blind, multicenter,

✍ Hiroyoshi Ohta, Hiroshi Oka, Chie Usui, Masayuki Ohkura, Makoto Suzuki, Kusuki N 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 370 KB

Rationale and Design of the Multicenter,

✍ Mihai Gheorghiade; Cesare Orlandi; John C. Burnett Jr.; David DeMets; Liliana Gr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB